Hyoscine Butylbromide for Prevention of Bradycardia During Cesarean Section

Phase 4 Completed 173 enrolled Assiut University

RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of this study is to assess the efficacy of Iv hyoscine butylbromide in preventing Bradycardia during cesarean section under spinal anaesthesia with local anaesthetic and morphine.

Timeline

Start: 2019-10-10
Primary completion: 2020-02-25
Completion: 2020-02-25

Publications

Abbas MS, Hassan SA, Abbas AM, Thabet AM, Thabet AM, Mahdy MM. Hemodynamic and antiemetic effects of prophylactic hyoscine butyl-bromide during cesarean section under spinal anesthesia: a randomized controlled trial. BMC Anesthesiol. 2022 Apr 21;22(1):112. doi: 10.1186/s12871-022-01659-9.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Hyoscine butylbromide	Unknown	20 mg	Intravenous

Indications

No indication recorded.